文献速递消化系统肿瘤

IV期结直肠癌患者的收入、治疗模式与生存结局

Income, treatment patterns and outcome in patients with stage IV colorectal cancer.
PubMed 文献 · Eur J Cancer · 2026-04-05

该研究基于荷兰癌症登记2015–2023年IV期结直肠癌患者24666例,按邮编区域收入分组,分析收入与筛查诊断、治疗及生存的关系。结果显示高收入组更常经筛查发现、更常接受转移灶根治性治疗及全身治疗,3年相对生存率更高(26% vs 22% vs 21%),校正后高收入较低收入死亡相对超额风险为0.93(95%CI 0.90-0.97)。

要点

  • 高收入组IV期结直肠癌患者更常通过筛查确诊(9% vs 8% vs 6%)。
  • 高收入组更常接受肝/腹膜转移根治性治疗及全身治疗。
  • 高收入组3年相对生存率26%,高于中/低收入组的22%和21%。

核心结论

  • 高收入IV期结直肠癌患者更可能接受肿瘤导向治疗(含根治性意图治疗),可能解释其观察到的更长生存。

研究设计与样本

  • 基于荷兰癌症登记,纳入2015–2023年诊断的IV期结直肠癌患者24666例,按邮编区域收入分为高(33%)、中(35%)、低(32%)三组。
  • 采用多变量logistic回归分析收入与治疗的关联,计算按收入分层的粗相对生存及多变量广义线性模型的相对超额死亡风险。

主要发现

  • 高、中、低收入组经筛查发现的比例分别为9%、8%、6%(p < 0.001)。
  • 单器官转移患者中,高收入组更常接受肝转移根治性治疗(40% vs 35% vs 29%,p < 0.001)和腹膜转移根治性治疗(36% vs 29% vs 22%,p < 0.001),多变量分析结果一致。
  • 高收入组全身治疗比例更高(56% vs 51% vs 42%,p < 0.001)。
  • 粗3年相对生存率:低收入21%、中收入22%、高收入26%;校正后高收入 vs 低收入相对超额风险0.93(95%CI 0.90-0.97),中收入 vs 低收入0.95(95%CI 0.92-0.99)。

临床怎么用

  • 应关注IV期结直肠癌治疗中收入相关差异,尤其筛查诊断途径及转移灶根治性治疗和全身治疗的可及性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: This study explores the association between income and patient- and treatment characteristics, diagnosis through screening and survival of patients with synchronous metastasized CRC. METHODS: Patients diagnosed with stage IV CRC between 2015 and 2023 were selected from the Netherlands Cancer Registry. Income at postal code level was used (Statistics Netherlands). Multivariable logistic regression analyses were used to determine the association between income and treatment. Crude relative survival stratified for income was calculated, as well as relative excess risks of death using a multivariable generalized linear model. RESULTS: The study included 24,666 patients, with respectively 33%, 35% and 32% having higher, intermediate and lower income. Detection through screening was more often realized in the higher income group compared to intermediate and lower income (9% vs. 8% vs.6%, p < 0.001). Among patients with single-organ metastases, higher income patients were more often treated with curative intent for metastases to the liver (40% vs. 35% vs. 29%, p < 0.001) and peritoneum (36% vs. 29% vs.22%, p < 0.001) compared to intermediate or lower income, also in multivariable analyses. Similarly, systemic therapy was given more frequently to patients with higher income than those with intermediate or lower income (56% vs. 51% vs.42%, p < 0.001). Crude 3-year relative survival was 21% (lower), 22% (intermediate) and 26% (higher income, adjusted RER higher vs. lower income: 0.93, [95%CI 0.90-0.97]; intermediate vs. lower income: 0.95, [95%CI 0.92-0.99]). CONCLUSIONS: Patients with higher income were more likely to receive tumour directed treatment, including curative intent treatment which may result in the observed longer survival.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Galanos LJK, Elferink MAG, Lurvink RJ, et al. Income, treatment patterns and outcome in patients with stage IV colorectal cancer. Eur J Cancer. 2026. PMID: 41966682. doi:10.1016/j.ejca.2026.116732

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。